BIOLUX P-III BENELUX All-Comers Registry

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

February 24, 2017

Primary Completion Date

June 9, 2020

Study Completion Date

April 27, 2021

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Passeo-18 Lux DCB

The decision to treat the patient with Passeo-18 DCB is at the investigator discretion. The endovascular procedure is performed as per standard of care and device Instructions For Use (IFU)

Trial Locations (9)

Unknown

Ziekenhuis Oost Limburg Genk, Genk

University Hospital Gent (UZ Gent), Ghent

Algemeen Ziekenhuis Groeninge Kortrijk, Kortrijk

Algemeen Ziekenhuis Delta Roeselare, Roeselare

AZ Portaels, Vilvoorde

Centre Hospitaliers Luxembourg, Luxembourg

OLVG, Amsterdam

Maasstad Ziekenhuis, Rotterdam

Maxima Medisch Centrum Veldhoven, Veldhoven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biotronik AG

INDUSTRY

NCT03052309 - BIOLUX P-III BENELUX All-Comers Registry | Biotech Hunter | Biotech Hunter